Ontario Teachers Pension Plan Board Takes $363,000 Position in HealthEquity, Inc. (NASDAQ:HQY)

Ontario Teachers Pension Plan Board bought a new position in HealthEquity, Inc. (NASDAQ:HQY) in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The firm bought 4,442 shares of the company’s stock, valued at approximately $363,000.

Other large investors have also recently made changes to their positions in the company. GM Advisory Group LLC increased its position in shares of HealthEquity by 300.8% during the fourth quarter. GM Advisory Group LLC now owns 120,355 shares of the company’s stock worth $7,980,000 after acquiring an additional 90,329 shares during the period. Vontobel Holding Ltd. increased its holdings in HealthEquity by 96.3% during the 4th quarter. Vontobel Holding Ltd. now owns 73,564 shares of the company’s stock worth $4,877,000 after purchasing an additional 36,085 shares during the period. Mackenzie Financial Corp increased its holdings in HealthEquity by 58.2% during the 4th quarter. Mackenzie Financial Corp now owns 1,807,407 shares of the company’s stock worth $119,831,000 after purchasing an additional 664,979 shares during the period. Forest Hill Capital LLC bought a new stake in HealthEquity during the 4th quarter valued at $2,021,000. Finally, Norges Bank purchased a new stake in shares of HealthEquity in the 4th quarter worth $43,482,000. 99.55% of the stock is owned by hedge funds and other institutional investors.

HealthEquity Price Performance

Shares of HealthEquity stock traded up $2.06 during trading hours on Monday, reaching $75.44. The stock had a trading volume of 985,522 shares, compared to its average volume of 619,221. HealthEquity, Inc. has a twelve month low of $61.50 and a twelve month high of $88.26. The company has a current ratio of 4.39, a quick ratio of 4.39 and a debt-to-equity ratio of 0.44. The firm has a market capitalization of $6.56 billion, a PE ratio of 82.07, a PEG ratio of 1.23 and a beta of 0.57. The stock’s 50 day moving average is $81.34 and its 200 day moving average is $79.74.

HealthEquity (NASDAQ:HQY) last released its quarterly earnings results on Monday, June 3rd. The company reported $0.55 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.47 by $0.08. The firm had revenue of $287.60 million for the quarter, compared to analysts’ expectations of $278.78 million. HealthEquity had a net margin of 7.71% and a return on equity of 7.77%. Equities analysts expect that HealthEquity, Inc. will post 2.12 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Several equities research analysts have recently weighed in on the stock. KeyCorp upped their price target on shares of HealthEquity from $95.00 to $100.00 and gave the stock an “overweight” rating in a research report on Wednesday, June 5th. Barrington Research increased their target price on HealthEquity from $100.00 to $105.00 and gave the company an “outperform” rating in a research report on Tuesday, June 4th. Bank of America reiterated a “buy” rating and issued a $105.00 target price on shares of HealthEquity in a report on Wednesday, July 3rd. Royal Bank of Canada reaffirmed an “outperform” rating and set a $92.00 price target on shares of HealthEquity in a research report on Tuesday, June 4th. Finally, Wells Fargo & Company boosted their target price on HealthEquity from $107.00 to $110.00 and gave the stock an “overweight” rating in a research note on Thursday, June 20th. One investment analyst has rated the stock with a hold rating and twelve have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, HealthEquity presently has an average rating of “Moderate Buy” and a consensus price target of $101.67.

Insiders Place Their Bets

In other HealthEquity news, Vice Chairman Stephen Neeleman sold 400 shares of HealthEquity stock in a transaction dated Tuesday, June 4th. The shares were sold at an average price of $85.00, for a total transaction of $34,000.00. Following the transaction, the insider now directly owns 90,515 shares of the company’s stock, valued at $7,693,775. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. In other HealthEquity news, CEO Jon Kessler sold 32,326 shares of the company’s stock in a transaction dated Monday, June 24th. The stock was sold at an average price of $82.83, for a total transaction of $2,677,562.58. Following the sale, the chief executive officer now owns 232,176 shares in the company, valued at approximately $19,231,138.08. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, Vice Chairman Stephen Neeleman sold 400 shares of the firm’s stock in a transaction that occurred on Tuesday, June 4th. The shares were sold at an average price of $85.00, for a total transaction of $34,000.00. Following the completion of the sale, the insider now directly owns 90,515 shares in the company, valued at approximately $7,693,775. The disclosure for this sale can be found here. Insiders have sold a total of 42,511 shares of company stock valued at $3,519,346 in the last 90 days. 2.20% of the stock is owned by insiders.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.